CLINICAL_TRIALS
trial_result
· 2010-05-19
Clinical Trial Update: Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD) [Phase 3]
Summary
A Phase 3 study evaluating pantoprazole for pediatric gastroesophageal reflux disease has completed, with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED | Results posted: 2010-05-19